Adrienne A M Zandbergen

Summary

Publications

  1. ncbi Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial
    Adrienne A M Zandbergen
    Department of Internal Medicine, Ikazia Hospital and Erasmus University Medical Centre, Rotterdam, The Netherlands
    Ann Intern Med 139:90-6. 2003
  2. ncbi The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre Rotterdam, The Netherlands
    Clin Endocrinol (Oxf) 64:203-8. 2006
  3. ncbi Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands
    Eur J Endocrinol 155:293-6. 2006
  4. ncbi Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Diabetes Care 29:1851-5. 2006
  5. ncbi Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Diabetes Care 30:3119-21. 2007

Detail Information

Publications5

  1. ncbi Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial
    Adrienne A M Zandbergen
    Department of Internal Medicine, Ikazia Hospital and Erasmus University Medical Centre, Rotterdam, The Netherlands
    Ann Intern Med 139:90-6. 2003
    ..The effect of angiotensin-receptor antagonists in normotensive diabetic patients with microalbuminuria has not yet been reported...
  2. ncbi The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre Rotterdam, The Netherlands
    Clin Endocrinol (Oxf) 64:203-8. 2006
    ..We investigated whether renal as well as haemodynamic effects of losartan are associated with changes in the IGF-I system in normotensive patients with type 2 diabetes mellitus (T2DM)...
  3. ncbi Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands
    Eur J Endocrinol 155:293-6. 2006
    ..RAS and RAS inhibition also influence the IGF-I system, which is important in glucose homeostasis. We investigated the effects of the angiotensin-receptor antagonist, losartan, on insulin resistance and IGF-I levels..
  4. ncbi Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Diabetes Care 29:1851-5. 2006
    ....
  5. ncbi Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria
    Adrienne A M Zandbergen
    Department of Internal Medicine, Erasmus University Medical Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Diabetes Care 30:3119-21. 2007